A Calcium-Sensing Receptor Defect is Unlikely in This Clinical Scenario
In a patient presenting with elevated PTH, hypercalcemia, and high 24-hour urinary calcium excretion, this biochemical profile is most consistent with primary hyperparathyroidism (PHPT), not a calcium-sensing receptor (CaSR) defect. 1
Understanding the Biochemical Distinction
The key to answering this question lies in understanding how CaSR defects (familial hypocalciuric hypercalcemia, FHH) differ from PHPT:
Typical PHPT Presentation
The biochemical triad described in your question represents classic primary hyperparathyroidism 1:
- Elevated PTH (inappropriate for the calcium level)
- Hypercalcemia
- Increased 24-hour urinary calcium excretion (>7.5 mmol/24h in men, >6.25 mmol/24h in women)
- Fractional excretion of calcium (FeCa) >2% 1, 2
CaSR Defect (FHH) Presentation
In contrast, calcium-sensing receptor defects cause 3:
- Hypercalcemia
- Inappropriately normal or elevated PTH
- Low or normal urinary calcium (not high)
- FeCa <2% (typically <1%) 1, 3
The Pathophysiology Explains the Difference
Why PHPT causes high urinary calcium: 4
- PTH increases renal calcium reabsorption in the distal tubule
- However, when blood calcium rises significantly, this "overtakes" the reabsorptive capacity
- Hypercalcemia increases the filtered calcium load at the glomerulus
- Hypercalcemia also inhibits the CaSR in the loop of Henle, reducing calcium reabsorption
- Net result: hypercalciuria despite PTH's calcium-retaining effects
Why CaSR defects cause low urinary calcium: 3
- Inactivating CaSR mutations impair the kidney's ability to sense elevated calcium
- The kidney continues to avidly reabsorb calcium despite hypercalcemia
- This creates the characteristic "hypocalciuric hypercalcemia" pattern
Critical Diagnostic Algorithm
When evaluating elevated PTH with hypercalcemia 1, 2:
Measure 24-hour urinary calcium AND calculate FeCa
- FeCa = (urinary Ca × plasma Cr) / (urinary Cr × plasma Ca)
Interpret the urinary calcium:
- FeCa >2% with elevated 24-hour urine calcium → PHPT (your patient's scenario)
- FeCa <1% with low/normal urine calcium → Consider FHH
- FeCa 1-2% → Borderline; consider genetic testing 5
If FeCa <2%, calculate Pro-FHH score or pursue genetic testing 1
Important Caveats
When FHH Can Mimic PHPT
There are rare atypical presentations of CaSR mutations that can confuse the picture 6, 7, 8:
- Some CaSR variants cause hypercalcemia with FeCa >2% and hypercalciuria
- These represent specific mutations affecting receptor function differently in parathyroid vs. kidney
- However, these are exceptional cases, not the typical presentation
When PHPT Can Mimic FHH
PHPT can present with inappropriately low urinary calcium when 3:
- Severe vitamin D deficiency (limits calcitriol production and intestinal calcium absorption)
- Renal insufficiency (reduces glomerular filtration)
- Very low dietary calcium intake
- Corticosteroid therapy
Critical point: These secondary factors must be excluded before considering FHH 1, 2
Definitive Recommendation
Your patient's presentation—elevated PTH, hypercalcemia, AND high 24-hour urinary calcium—strongly indicates primary hyperparathyroidism, not a calcium-sensing receptor defect. 1
The high urinary calcium excretion essentially rules out typical FHH. Proceed with:
- Confirming vitamin D sufficiency (>6 months of adequate levels) 2
- Excluding other causes of secondary hyperparathyroidism
- Evaluating for target organ involvement (bone density, kidney stones, nephrocalcinosis) 1
- Considering parathyroid imaging if surgery is contemplated 1
Genetic testing for CaSR mutations would only be warranted if 9:
- Family history of hypercalcemia
- Recurrent disease after parathyroidectomy
- FeCa unexpectedly drops below 2% on repeat testing
- Young age at presentation (<40 years) with multi-glandular disease